{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:28:53Z","timestamp":1786980533659,"version":"build-2736575974"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"2021 Fujian Province Mid-career and Young Teachers Education Research Projec","award":["JAT210127"],"award-info":[{"award-number":["JAT210127"]}]},{"name":"Joint Funds for the Innovation of Science and Technology, Fujian Province","award":["No. 2021Y9138"],"award-info":[{"award-number":["No. 2021Y9138"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10120-026-01718-x","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T13:23:29Z","timestamp":1773408209000},"page":"561-577","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Targeting the OXNAD1\u2013PTGS2 axis with resveratrol overcomes ferroptosis Inhibition and reverses 5-FU resistance in gastric cancer"],"prefix":"10.1007","volume":"29","author":[{"given":"Jinzhou","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bishuang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,13]]},"reference":[{"issue":"3","key":"1718_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"Cancer J Clin"},{"issue":"3","key":"1718_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"Cancer J Clin"},{"issue":"10251","key":"1718_CR3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","volume":"396","author":"EC Smyth","year":"2020","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet (London England). 2020;396(10251):635\u201348.","journal-title":"Lancet (London England)"},{"issue":"7","key":"1718_CR4","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.trecan.2024.03.008","volume":"10","author":"T Yasuda","year":"2024","unstructured":"Yasuda T, Wang YA. Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development. Trends Cancer. 2024;10(7):627\u201342.","journal-title":"Trends Cancer"},{"issue":"1","key":"1718_CR5","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1038\/s41467-023-38360-5","volume":"14","author":"C Sun","year":"2023","unstructured":"Sun C, Wang A, Zhou Y, Chen P, Wang X, Huang J, et al. Spatially resolved multi-omics highlights cell-specific metabolic remodeling and interactions in gastric cancer. Nat Commun. 2023;14(1):2692.","journal-title":"Nat Commun"},{"issue":"3\u20134","key":"1718_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s10495-022-01709-0","volume":"27","author":"P Tanprasert","year":"2022","unstructured":"Tanprasert P, Limpakan Yamada S, Chattipakorn SC, Chattipakorn N, Shinlapawittayatorn K. Targeting mitochondria as a therapeutic anti-gastric cancer approach. Apoptosis: Int J Program Cell Death. 2022;27(3\u20134):163\u201383.","journal-title":"Apoptosis: Int J Program Cell Death"},{"issue":"9","key":"1718_CR7","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1038\/s41556-024-01429-4","volume":"26","author":"HL Glover","year":"2024","unstructured":"Glover HL, Schreiner A, Dewson G, Tait SWG. Mitochondria and cell death. Nat Cell Biol. 2024;26(9):1434\u201346.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"1718_CR8","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41419-024-06691-w","volume":"15","author":"QY Zhou","year":"2024","unstructured":"Zhou QY, Ren C, Li JY, Wang L, Duan Y, Yao RQ, et al. The crosstalk between mitochondrial quality control and metal-dependent cell death. Cell Death Dis. 2024;15(4):299.","journal-title":"Cell Death Dis"},{"issue":"8","key":"1718_CR9","doi-asserted-by":"publisher","first-page":"1916","DOI":"10.1038\/s41418-023-01185-2","volume":"30","author":"Y Li","year":"2023","unstructured":"Li Y, Bie J, Zhao L, Song C, Zhang T, Li M, et al. SLC25A51 promotes tumor growth through sustaining mitochondria acetylation homeostasis and proline biogenesis. Cell Death Differ. 2023;30(8):1916\u201330.","journal-title":"Cell Death Differ"},{"issue":"4","key":"1718_CR10","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/j.cmet.2024.01.013","volume":"36","author":"MJ Lu","year":"2024","unstructured":"Lu MJ, Busquets J, Impedovo V, Wilson CN, Chan HR, Chang YT, et al. SLC25A51 decouples the mitochondrial NAD(+)\/NADH ratio to control proliferation of AML cells. Cell Metabol. 2024;36(4):808\u2013e821806.","journal-title":"Cell Metabol"},{"issue":"19","key":"1718_CR11","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1056\/NEJMoa2405195","volume":"391","author":"T Leong","year":"2024","unstructured":"Leong T, Smithers BM, Michael M, Haustermans K, Wong R, Gebski V, et al. Preoperative chemoradiotherapy for resectable gastric cancer. N Engl J Med. 2024;391(19):1810\u201321.","journal-title":"N Engl J Med"},{"key":"1718_CR12","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.radonc.2020.10.011","volume":"155","author":"M Li","year":"2021","unstructured":"Li M, Chen H, He J, Xie J, Xia J, Liu H, et al. A qualitative classification signature for post-surgery 5-fluorouracil-based adjuvant chemoradiotherapy in gastric cancer. Radiotherapy Oncology: J Eur Soc Therapeutic Radiol Oncol. 2021;155:65\u201372.","journal-title":"Radiotherapy Oncology: J Eur Soc Therapeutic Radiol Oncol"},{"key":"1718_CR13","doi-asserted-by":"publisher","first-page":"101080","DOI":"10.1016\/j.drup.2024.101080","volume":"74","author":"G Che","year":"2024","unstructured":"Che G, Yin J, Wang W, Luo Y, Chen Y, Yu X, et al. Circumventing drug resistance in gastric cancer: a spatial multi-omics exploration of chemo and immuno-therapeutic response dynamics. Drug Resist Updates: Reviews Commentaries Antimicrob Anticancer Chemother. 2024;74:101080.","journal-title":"Drug Resist Updates: Reviews Commentaries Antimicrob Anticancer Chemother"},{"issue":"7","key":"1718_CR14","first-page":"e2409050","volume":"12","author":"J Yu","year":"2025","unstructured":"Yu J, Chen M, Sang Q, Li F, Xu Z, Yu B, et al. Super-enhancer activates master transcription factor NR3C1 expression and promotes 5-FU resistance in gastric Cancer. Advanced science (Weinheim, Baden-Wurttemberg. Germany). 2025;12(7):e2409050.","journal-title":"Germany)"},{"key":"1718_CR15","doi-asserted-by":"publisher","first-page":"102317","DOI":"10.1016\/j.redox.2022.102317","volume":"52","author":"S Ouyang","year":"2022","unstructured":"Ouyang S, Li H, Lou L, Huang Q, Zhang Z, Mo J, et al. Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer. Redox Biol. 2022;52:102317.","journal-title":"Redox Biol"},{"issue":"6","key":"1718_CR16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41419-024-06832-1","volume":"15","author":"X Jiang","year":"2024","unstructured":"Jiang X, Zhu Z, Ding L, Du W, Pei D. ALKBH4 impedes 5-FU sensitivity through suppressing GSDME induced pyroptosis in gastric cancer. Cell Death Dis. 2024;15(6):435.","journal-title":"Cell Death Dis"},{"issue":"28","key":"1718_CR17","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1038\/s41388-025-03411-2","volume":"44","author":"H Huang","year":"2025","unstructured":"Huang H, Fang L, Zhu C, Lv J, Xu P, Chen Z, et al. YBX1 promotes 5-Fluorouracil resistance in gastric cancer via m5C-dependent ATG9A mRNA stabilization through autophagy. Oncogene. 2025;44(28):2357\u201371.","journal-title":"Oncogene"},{"key":"1718_CR18","doi-asserted-by":"crossref","unstructured":"Zhang W, Liu Y, Liao Y, Zhu C, Zou Z. GPX4, ferroptosis, and diseases. Volume 174. Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie; 2024. p. 116512.","DOI":"10.1016\/j.biopha.2024.116512"},{"issue":"8","key":"1718_CR19","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","volume":"12","author":"P Koppula","year":"2021","unstructured":"Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy. Protein Cell. 2021;12(8):599\u2013620.","journal-title":"Protein Cell"},{"key":"1718_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.freeradbiomed.2021.05.009","volume":"171","author":"Y Zhou","year":"2021","unstructured":"Zhou Y, Zhou H, Hua L, Hou C, Jia Q, Chen J, et al. Verification of ferroptosis and pyroptosis and identification of PTGS2 as the hub gene in human coronary artery atherosclerosis. Free Radic Biol Med. 2021;171:55\u201368.","journal-title":"Free Radic Biol Med"},{"key":"1718_CR21","doi-asserted-by":"crossref","unstructured":"Qu X, Liu B, Wang L, Liu L, Zhao W, Liu C et al. Loss of cancer-associated fibroblast-derived Exosomal DACT3-AS1 promotes malignant transformation and ferroptosis-mediated oxaliplatin resistance in gastric cancer. Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy 2023;68:100936.","DOI":"10.1016\/j.drup.2023.100936"},{"issue":"1","key":"1718_CR22","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/s41419-025-07621-0","volume":"16","author":"C Huang","year":"2025","unstructured":"Huang C, Zeng Q, Chen J, Wen Q, Jin W, Dai X, et al. TMEM160 inhibits KEAP1 to suppress ferroptosis and induce chemoresistance in gastric cancer. Cell Death Dis. 2025;16(1):287.","journal-title":"Cell Death Dis"},{"key":"1718_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.canlet.2021.05.001","volume":"515","author":"B Ren","year":"2021","unstructured":"Ren B, Kwah MX, Liu C, Ma Z, Shanmugam MK, Ding L, et al. Resveratrol for cancer therapy: challenges and future perspectives. Cancer Lett. 2021;515:63\u201372.","journal-title":"Cancer Lett"},{"key":"1718_CR24","doi-asserted-by":"crossref","unstructured":"Jang JY, Im E, Kim ND. Mechanism of Resveratrol-Induced programmed cell death and new drug discovery against cancer: a review. Int J Mol Sci 2022, 23(22).","DOI":"10.3390\/ijms232213689"},{"issue":"1","key":"1718_CR25","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1186\/s12903-024-04395-3","volume":"24","author":"C Mao","year":"2024","unstructured":"Mao C, Gong L, Kang W. Effect and mechanism of Resveratrol on ferroptosis mediated by p53\/SLC7A11 in oral squamous cell carcinoma. BMC Oral Health. 2024;24(1):773.","journal-title":"BMC Oral Health"},{"key":"1718_CR26","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.neuro.2021.10.007","volume":"87","author":"M Hu","year":"2021","unstructured":"Hu M, Wang R, Chen X, Zheng M, Zheng P, Boz Z, et al. Resveratrol prevents haloperidol-induced mitochondria dysfunction through the induction of autophagy in SH-SY5Y cells. Neurotoxicology. 2021;87:231\u201342.","journal-title":"Neurotoxicology"},{"key":"1718_CR27","doi-asserted-by":"crossref","unstructured":"Kursvietiene L, Kopustinskiene DM, Staneviciene I, Mongirdiene A, Kubov\u00e1 K, Masteikova R et al. Anti-Cancer properties of resveratrol: a focus on its impact on mitochondrial functions. Antioxid (Basel Switzerland) 2023, 12(12).","DOI":"10.3390\/antiox12122056"},{"issue":"3","key":"1718_CR28","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3892\/ol.2024.14225","volume":"27","author":"R Zhang","year":"2024","unstructured":"Zhang R, Lu M, Zhang Z, Tian X, Wang S, Lv D, Erratum. [Corrigendum] Resveratrol reverses P\u2013glycoprotein\u2013mediated multidrug resistance of U2OS\/ADR cells by suppressing the activation of the NF\u2013\u03baB and p38 MAPK signaling pathways. Oncol Lett. 2024;27(3):92.","journal-title":"Oncol Lett"},{"key":"1718_CR29","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.freeradbiomed.2025.04.052","volume":"235","author":"E Zhang","year":"2025","unstructured":"Zhang E, Wang Y, Zhang H, Li X, Su Y, Cui J, et al. Resveratrol induces ferroptosis in triple-negative breast cancer through NEDD4L-mediated GPX4 ubiquitination and degradation. Free Radic Biol Med. 2025;235:231\u201347.","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"1718_CR30","doi-asserted-by":"publisher","first-page":"2541","DOI":"10.1038\/s41467-025-57536-9","volume":"16","author":"H Hadipour","year":"2025","unstructured":"Hadipour H, Li YY, Sun Y, Deng C, Lac L, Davis R, et al. GraphBAN: an inductive graph-based approach for enhanced prediction of compound-protein interactions. Nat Commun. 2025;16(1):2541.","journal-title":"Nat Commun"},{"issue":"34","key":"1718_CR31","doi-asserted-by":"publisher","first-page":"35922","DOI":"10.18632\/oncotarget.5771","volume":"6","author":"E Denisova","year":"2015","unstructured":"Denisova E, Heidenreich B, Nagore E, Rachakonda PS, Hosen I, Akrap I, et al. Frequent DPH3 promoter mutations in skin cancers. Oncotarget. 2015;6(34):35922\u201330.","journal-title":"Oncotarget"},{"issue":"12","key":"1718_CR32","doi-asserted-by":"publisher","first-page":"2464","DOI":"10.1016\/j.cmet.2021.11.001","volume":"33","author":"M Morgenstern","year":"2021","unstructured":"Morgenstern M, Peikert CD, L\u00fcbbert P, Suppanz I, Klemm C, Alka O, et al. Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context. Cell Metabol. 2021;33(12):2464\u2013e24832418.","journal-title":"Cell Metabol"},{"issue":"12","key":"1718_CR33","doi-asserted-by":"publisher","first-page":"2215","DOI":"10.1016\/j.molcel.2022.03.022","volume":"82","author":"D Liang","year":"2022","unstructured":"Liang D, Minikes AM, Jiang X. Ferroptosis at the intersection of lipid metabolism and cellular signaling. Mol Cell. 2022;82(12):2215\u201327.","journal-title":"Mol Cell"},{"key":"1718_CR34","doi-asserted-by":"publisher","first-page":"111163","DOI":"10.1016\/j.cbi.2024.111163","volume":"400","author":"L Zeng","year":"2024","unstructured":"Zeng L, Zhao W, Han T, Qing F, He Z, Zhao Q, et al. Ropivacaine prompts ferroptosis to enhance the cisplatin-sensitivity of human colorectal cancer through SIRT1\/Nrf2 signaling pathway. Chemico-Biol Interact. 2024;400:111163.","journal-title":"Chemico-Biol Interact"},{"key":"1718_CR35","doi-asserted-by":"publisher","first-page":"1482354","DOI":"10.3389\/fphar.2024.1482354","volume":"15","author":"C Zhang","year":"2024","unstructured":"Zhang C, Zhan S, He Y, Pan Z, You Z, Zhu X, et al. Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy. Front Pharmacol. 2024;15:1482354.","journal-title":"Front Pharmacol"},{"issue":"3","key":"1718_CR36","doi-asserted-by":"publisher","first-page":"280","DOI":"10.2174\/1874467215666220415131344","volume":"16","author":"S Mirzaei","year":"2023","unstructured":"Mirzaei S, Gholami MH, Zabolian A, Saleki H, Bagherian M, Torabi SM, et al. Resveratrol augments doxorubicin and cisplatin chemotherapy: a novel therapeutic strategy. Curr Mol Pharmacol. 2023;16(3):280\u2013306.","journal-title":"Curr Mol Pharmacol"},{"issue":"1","key":"1718_CR37","first-page":"66","volume":"24","author":"RF \u00d6zdemi","year":"2021","unstructured":"\u00d6zdemi RF, Sever A, Ke\u00e7eci Y, Incesu Z. Resveratrol increases the sensitivity of breast cancer MDA-MB-231 cell line to cisplatin by regulating intrinsic apoptosis. Iran J Basic Med Sci. 2021;24(1):66\u201372.","journal-title":"Iran J Basic Med Sci"},{"issue":"1","key":"1718_CR38","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/s42003-022-04055-8","volume":"5","author":"MC Ludikhuize","year":"2022","unstructured":"Ludikhuize MC, Gevers S, Nguyen NTB, Meerlo M, Roudbari SKS, Gulersonmez MC, et al. Rewiring glucose metabolism improves 5-FU efficacy in p53-deficient\/KRAS(G12D) glycolytic colorectal tumors. Commun Biology. 2022;5(1):1159.","journal-title":"Commun Biology"},{"issue":"1","key":"1718_CR39","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41392-023-01347-1","volume":"8","author":"H Wang","year":"2023","unstructured":"Wang H, Guo M, Wei H, Chen Y. Targeting p53 pathways: mechanisms, structures, and advances in therapy. Signal Transduct Target Therapy. 2023;8(1):92.","journal-title":"Signal Transduct Target Therapy"},{"issue":"1","key":"1718_CR40","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s42003-022-03705-1","volume":"5","author":"P Santofimia-Casta\u00f1o","year":"2022","unstructured":"Santofimia-Casta\u00f1o P, Huang C, Liu X, Xia Y, Audebert S, Camoin L, et al. NUPR1 protects against hyperPARylation-dependent cell death. Commun Biology. 2022;5(1):732.","journal-title":"Commun Biology"},{"issue":"2","key":"1718_CR41","doi-asserted-by":"publisher","first-page":"102226","DOI":"10.1016\/j.esmoop.2023.102226","volume":"9","author":"K Shitara","year":"2024","unstructured":"Shitara K, Fleitas T, Kawakami H, Curigliano G, Narita Y, Wang F, et al. Pan-Asian adapted ESMO clinical practice guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer. ESMO Open. 2024;9(2):102226.","journal-title":"ESMO Open"},{"issue":"2","key":"1718_CR42","doi-asserted-by":"publisher","first-page":"167","DOI":"10.6004\/jnccn.2022.0008","volume":"20","author":"JA Ajani","year":"2022","unstructured":"Ajani JA, D\u2019Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, et al. Gastric Cancer, version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Network: JNCCN. 2022;20(2):167\u201392.","journal-title":"J Natl Compr Cancer Network: JNCCN"},{"issue":"3","key":"1718_CR43","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s13577-025-01195-x","volume":"38","author":"Y Niu","year":"2025","unstructured":"Niu Y, Liu C, Jia L, Zhao F, Wang Y, Wang L, et al. STX1A regulates ferroptosis and chemoresistance in gastric cancer through mitochondrial function modulation. Hum Cell. 2025;38(3):66.","journal-title":"Hum Cell"},{"key":"1718_CR44","first-page":"1","volume":"8","author":"Y Yang","year":"2025","unstructured":"Yang Y, Yu S, Liu W, Zhuo Y, Qu C, Zeng Y. Ferroptosis-related signaling pathways in cancer drug resistance. Cancer Drug Resist (Alhambra Calif). 2025;8:1.","journal-title":"Cancer Drug Resist (Alhambra Calif)"},{"issue":"1","key":"1718_CR45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-022-01530-y","volume":"21","author":"C Zhang","year":"2022","unstructured":"Zhang C, Liu X, Jin S, Chen Y, Guo R. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer. 2022;21(1):47.","journal-title":"Mol Cancer"},{"issue":"4","key":"1718_CR46","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1038\/s43018-023-00715-8","volume":"5","author":"H Zheng","year":"2024","unstructured":"Zheng H, Liu J, Cheng Q, Zhang Q, Zhang Y, Jiang L, et al. Targeted activation of ferroptosis in colorectal cancer via LGR4 targeting overcomes acquired drug resistance. Nat Cancer. 2024;5(4):572\u201389.","journal-title":"Nat Cancer"},{"issue":"1","key":"1718_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00432-025-06372-x","volume":"152","author":"Y Liu","year":"2025","unstructured":"Liu Y, Jia L, Yang L, Ning Z, Li Y. Research progress on ferroptosis in drug resistance and therapy of gastric cancer. J Cancer Res Clin Oncol. 2025;152(1):1.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"1","key":"1718_CR48","doi-asserted-by":"publisher","first-page":"24515","DOI":"10.1038\/s41598-025-08665-0","volume":"15","author":"J Wang","year":"2025","unstructured":"Wang J, Liu T, Chen P, Yin D, Zhang H, Qiu X, et al. Pharmacokinetic evaluation of two oral Resveratrol formulations in a randomized, open-label, crossover study in healthy fasting subjects. Sci Rep. 2025;15(1):24515.","journal-title":"Sci Rep"},{"issue":"1","key":"1718_CR49","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/ptr.8379","volume":"39","author":"I Szymkowiak","year":"2025","unstructured":"Szymkowiak I, Marcinkowska J, Kucinska M, Regulski M, Murias M. Resveratrol bioavailability after oral administration: A Meta-Analysis of clinical trial data. Phytother Res. 2025;39(1):453\u201364.","journal-title":"Phytother Res"}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-026-01718-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10120-026-01718-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-026-01718-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:08:34Z","timestamp":1777388914000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10120-026-01718-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,13]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1718"],"URL":"https:\/\/doi.org\/10.1007\/s10120-026-01718-x","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,13]]},"assertion":[{"value":"13 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no declarations of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research is reviewed by the Ethics Committee of the First Affiliated Hospital of Fujian Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}